MIT increase weight of the METH-treated rats
The final weight of the METH group (230.6 ± 8.12) significantly decreased compared to the saline group (257.5 ± 14.15); q (20) = 4.29, p = 0.030. The METH + MIT (258.4 ± 14.22) and MIT (270.3 ± 23.97) groups had significant weight gains compared to the METH group q (20) = 6.34, p = 0.034; q (20) = 4.22, p = 0.001. (Figure 1). One way ANOVA test showed F (3, 20) = 7 p = 0.002.
MIT improves learning in the METH treated rats
To measure learning in the first 4 days of the MWM test, the total distance traveled to find the hidden platform was assessed. Our data did not show any significant difference between the groups, but in the first 4 days of the learning phase, significant differences were observed within the groups. There was a significant difference in the saline group on the first day with days 2, 3, and 4 (P = 0.009, P = 0.010, and P < 0.001, respectively). Furthermore, the METH group had a significant difference on the first day with days 3 and 4 (P = 0.003 and P < 0.001, respectively). The METH + MIT group demonstrated a significant difference on the first day with days 3 and 4 (P = 0.014 and P = 0.002); in addition, the second day also showed a significant difference with days 3 and 4 (P = 0.024 and P = 0.005, respectively). Finally, the first day of the MIT group indicated a significant difference with days 2, 3, and 4 (P = 0.004, P = 0.026, and P = 0.004, respectively) (Figure 2A).
MIT improves memory in the METH treated rats
There was a significant difference in the percentage of distance traveled (2.40±0.66) q(28)=8.41, p<0.001, time spent (26.01±6.70), q(28)=9.52, p<0.001, and frequency (4.43±0.98), q(24)=7.96, p<0.001 in the target quadrant for the METH compared with the saline group [(5.28±0.90), (55.13±10.98), (7.85±1.12), respectively]. MIT ameliorated distance (3.76±1.18), q (28)=3.97, p=0.042, time (44.35±7.90), q(28)=5.99, p=0.001, and frequency (6.57±0.97), q(24)=4.97, p=0.009). In addition, a significant difference was found in the percentage of distance, time spent and frequency between MIT [(4.01±1.05), q (28) =4.71, p=0.012, time (48.74±8.45), q(28)=7.43, p<0.001, and frequency (6.85±1.34), q (24)=5.64, p=0.003)] and METH groups (Fig. 2B, C, D).
MIT ameliorates hippocampal antioxidant status in the METH treated rats
The results of the statistical analysis on biochemical parameters of rat hippocampal tissue showed a significant difference between the groups. The MDA level in the METH (0.041±0.009) group was significantly increased compared with the saline group (0.028±0.001), q (24) =5.92, p=0.002). MIT (0.022±0.003) markedly decreased the MDA level compared to the METH group q (24) =8.30, p< 0.001. METH injection significantly decreased the levels of antioxidant enzymes GPx (5.46±0.32), q (24)=14.45, p<0.001, SOD (0.051±0.005), q (24)=13.90, p<0.001) CAT (10.92±1.24), q (24)=5.50, p=0.004) and TAC (3.07±0.32), q (24)=9.93, p<0.001) in the treated group compared to saline [(7.91±0.46), (0.074±0.004), (14.29±1.32) and (4.17±0.27), respectively. MIT improved this reduction [(6.63±0.48), q (24) =6.88, p<0.001); (0.65±0.002), q (24) = 8.01, p<0.001); (12.83±1.31), q (24) =3.11, p=0.15); (3.35±0.31), q (24) =2.48, p=0.31), respectively)] (Figure 3).
MIT changes gene expression of the hippocampus in the METH treated rats
There was a significant elevation in CDK5 gene expression in the METH group (2.4±0.67) compared to the saline group (1.0±0.02), t (6.02) =5.50, P=0.008). Moreover, the decline in CDK5 expression in METH + MIT (1.16±0.14) and MIT (0.90±0.08) groups compared to the METH group was statistically significant, (t (6.52) =4.78, P=0.01) and t (6.18) =5.87, P=0.005, respectively) (Fig. 4A).
The α-synuclein gene expressed a higher level in the METH group (2.92±0.57) compared to the saline group (1.0±0.03), t(6.03)=8.80, (p<0.001), and MIT (1.49± 0.30) t(8.98)=5.85, p=0.001) diminished this elevated level. In addition, a significant difference was found between the MIT (0.83±0.15) and METH+MIT groups (t (9.29)=5.22, p=0.003) (Figure 4B).
Increased expression of Tau (1.60±0.40) and p-Tau (1.87±0.52) genes were significant in the METH group compared to the saline group (1.0±0.02), t(6.05)=3.92, (p=0.038); t(6.03)=4.39, p=0.02), respectively); moreover, the decrease in Tau (1.03±0.12, 0.95±0.10) and p-Tau (1.16±0.10, 0.94±0.08) expressions in METH + MIT and MIT groups compared to the METH group was statistically significant [t(7.12)=3.60, (p=0.043); t(6.78)=4.20, p=0.021); t(6.51)=3.53, (p=0.047); t(6.34)=4.63, p=0.018), respectively] (Figures 4C, D).